STOCK TITAN

Evoke Pharma, Inc. (EVOK) Revenue by Year

EVOK

Evoke Pharma, Inc. generated $10.2M in revenue in fiscal year 2024. This represents an increase of 97.8% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $14.4M in revenue. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Evoke Pharma, Inc. has filed alongside them.

FY2024 annual
Revenue $10.2M
YoY +97.8%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EVOK Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
Revenue$14.4M$10.2M+97.8%$5.2M+106.5%$2.5M+55.0%$1.6M+6929.0%$23KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

EVOK Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Revenue$4.3M+61.4%$3.8M+47.1%$3.1M+77.5%$3.3M+97.4%$2.7M+69.8%$2.6M+125.5%$1.7M+114.2%$1.7M+110.5%$1.6M+87.8%$1.1M+145.0%$810K+93.7%$796K+120.9%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Evoke Pharma, Inc. financials

Frequently Asked Questions

What was Evoke Pharma, Inc.'s revenue in fiscal year 2024?

Evoke Pharma, Inc. generated $10.2M in revenue in fiscal year 2024.

How fast is Evoke Pharma, Inc.'s revenue growing?

Evoke Pharma, Inc. (EVOK) revenue rose by 97.8% year over year, from $5.2M to $10.2M in fiscal year 2024.

What is Evoke Pharma, Inc.'s revenue over the last twelve months?

Evoke Pharma, Inc. (EVOK) reported $14.4M in revenue over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Evoke Pharma, Inc. (EVOK) reported $4.3M in revenue in Q3 2025. This represents an increase of 61.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Evoke Pharma, Inc. (EVOK) reported on that line in every period on record.